Clinical trials recruiting in Zaozhuang, China

Phase breakdown

Conditions recruiting in Zaozhuang, China

Recruiting trials in Zaozhuang, China

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
  NCT07010263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
  NCT04974138 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
  NCT04974151 · Phase: Phase 4 · Ages: 45 Years to 74 Years · Sex: All (male and female)
• Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
  NCT03349762 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Phase II Study of RC1416 Injection in COPD
  NCT07402551 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female)
• TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
  NCT06829784 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Zaozhuang, China?

7 recruiting trials have at least one study site in Zaozhuang, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.